Follow
Lara Albert Fàbregas
Lara Albert Fàbregas
Médico adjunto Endocrinología y Nutrición, Hospital Parc Taulí de Sabadell
No verified email
Title
Cited by
Cited by
Year
Prevención cardiovascular primaria con estatinas en la diabetes mellitus tipo 2:¿ es hora de cambiar de estrategia?
L Albert Fabregas, JM González Clemente
Med. clín (Ed. impr.), 358-359, 2014
42014
Factors affecting glycemic outcomes using closed-loop systems in real-world
LA Fabregas, DS Andujar, AR Gregori, MF Luchtenberg, AC Palomares, ...
Endocrine Abstracts 81, 2022
2022
Utility of insulin resistance in estimating cardiovascular risk in subjects with type 1 diabetes according to the scores of the Steno Type 1
RS Canonge, A Cano, I Mazarico, B Astiarraga, M González-Sastre, ...
Journal of Clinical Medicine 9 (7), 2020
2020
Type 1 diabetes mellitus: defining the best cut-off points of arterial stiffness for predicting cardiovascular risk according to the Steno Type 1 Risk Engine
A Cano, G Llaurado, LA Fabregas, I Mazarico, M Gonzalez-Sastre, ...
Endocrine Abstracts 56, 2018
2018
Guia Clínica per al diagnòstic i tractament de la CETOACIDOSI DIABÈTICA (CAD) i el COMA HIPEROSMOLAR NO CETÒTIC (CHNC) en l'àmbit hospitalari
C GUIES, AC Pedragós
The system can't perform the operation now. Try again later.
Articles 1–5